Skip to main content

Table 2 Clinicopathological features of the 11 PTBC patients

From: Breast cancer after kidney transplantation: a single institution review

Patient Age Duration to diagnosis (months) Procedure Stage Positivity of hormone receptor Type of chemotherapya Recurrence Status Follow-up duration (months)
1 42 42 SM with SLNB I + - - Alive 127
2 49 6 MRM I + - - Alive 119
3 28 127 MRM III - CAF(×6) Bone, lung Dead 95
4 24 134 Excision biopsy Unknown - - - Alive 146
5 40 177 SM with SLNB I - - - Alive 101
6 43 181 MRM III - CMF(×6) + AT(×4) Bone, lung, liver Dead 30
7 35 89 MRM III - AC(×4) + T(×4) - Alive 49
8 28 354 SM with SLNB II + AC(×4) - Alive 8
9 29 176 WE with SLNB I + - - Alive 37
10 29 208 SM with SLNB I - - - Alive 28
11 38 8 MRM III + AC(×4) - Alive 17
  1. aC: cyclophosphamide, M: methotrexate, F: 5-fluorouracil, A: adriamycin, T: taxotere.
  2. MRM: modified radical mastectomy; SLNB: sentinel lymph node biopsy;SM: simple mastectomy;WE: wide excision.